TY  - GEN
AU  - Batalla,Ana
AU  - González-Fernández,Daniel
AU  - González-Lara,Leire
AU  - Abalde,Teresa
AU  - Salgado-Boquete,Laura
AU  - Queiro-Silva,Rubén
AU  - Coto,Eliecer
AU  - Coto-Segura,Pablo
TI  - Cardiovascular risk factors influence response to biological therapies in psoriasis
SN  - 1097-6787
PY  - 2015///1006
KW  - Adalimumab
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Biological Therapy
KW  - adverse effects
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - Comorbidity
KW  - Cross-Sectional Studies
KW  - Dose-Response Relationship, Drug
KW  - Etanercept
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunoglobulin G
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Psoriasis
KW  - Receptors, Tumor Necrosis Factor
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Severity of Illness Index
KW  - Spain
KW  - Time Factors
KW  - Treatment Outcome
KW  - Ustekinumab
N1  - Publication Type: Comparative Study; Letter; Observational Study
UR  - https://doi.org/10.1016/j.jaad.2015.04.041
ER  -